Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open, Parallel, Single-Site Study to Evaluate Sensitivity and Specificity of Newly Defined Diagnosed-biomarker for Gastric Cancer Pts and Cancer-free Healthy Volunteers

NCT02848066 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT02848066
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02848066 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open, Parallel, Single-Site Study to Evaluate Sensitivity and Specificity of Newly Defined Diagnosed-biomarker for Gastric Cancer Pts and Cancer-free Healthy Volunteers
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
July 31, 2015
Completion date
September 30, 2017
Enrollment
353 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer